Miura M - Search Results

1

Plasma concentration of osimertinib in a non-small cell lung cancer patient with chronic renal failure undergoing hemodialysis.

Tamura T, Takagi Y, Okubo H, Yamaguchi S, Kikkawa Y, Hashimoto I, Kaburagi T, Miura M, Satoh H, Hizawa N. Tamura T, et al. Among authors: miura m. Lung Cancer. 2017 Oct;112:225-226. doi: 10.1016/j.lungcan.2017.07.007. Epub 2017 Jul 8. Lung Cancer. 2017. PMID: 28709627 No abstract available.

2

Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer.

Kobayashi H, Sato K, Niioka T, Miura H, Ito H, Miura M. Kobayashi H, et al. Among authors: miura h, miura m. Clin Lung Cancer. 2015 Jul;16(4):274-81. doi: 10.1016/j.cllc.2014.12.004. Epub 2014 Dec 11. Clin Lung Cancer. 2015. PMID: 25554506 Clinical Trial.

3

Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer.

Yokota H, Sato K, Okuda Y, Kobayashi H, Takeda M, Asano M, Ito H, Miura M. Yokota H, et al. Among authors: miura m. Clin Lung Cancer. 2017 Nov;18(6):e433-e439. doi: 10.1016/j.cllc.2017.05.010. Epub 2017 May 10. Clin Lung Cancer. 2017. PMID: 28579188

4

Effects of STAT3 polymorphisms and pharmacokinetics on the clinical outcomes of gefitinib treatment in patients with EGFR-mutation positive non-small cell lung cancer.

Yokota H, Sato K, Sakamoto S, Okuda Y, Asano M, Takeda M, Nakayama K, Miura M. Yokota H, et al. Among authors: miura m. J Clin Pharm Ther. 2020 Aug;45(4):652-659. doi: 10.1111/jcpt.13173. Epub 2020 May 13. J Clin Pharm Ther. 2020. PMID: 32402096

5

Low plasma concentration of gefitinib in patients with EGFR exon 21 L858R point mutations shortens progression-free survival.

Okuda Y, Sato K, Sudo K, Hasegawa Y, Asano M, Miura H, Takeda M, Sano M, Watanabe H, Kobayashi H, Niioka T, Miura M, Ito H. Okuda Y, et al. Among authors: miura h, miura m. Cancer Chemother Pharmacol. 2017 May;79(5):1013-1020. doi: 10.1007/s00280-017-3285-x. Epub 2017 Apr 8. Cancer Chemother Pharmacol. 2017. PMID: 28391354

6

Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease.

Mori J, Oshima K, Tanimoto T, Ishizuka H, Kimura S, Miura M, Takahashi N. Mori J, et al. Among authors: miura m. Int J Hematol. 2020 Jul;112(1):115-117. doi: 10.1007/s12185-020-02846-5. Epub 2020 Mar 9. Int J Hematol. 2020. PMID: 32152879

7

The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia.

Taniguchi Y, Takahashi N, Miura M, Hirase C, Sueda S, Espinoza JL, Rai S, Nakayama S, Serizawa K, Kumode T, Watatani Y, Morita Y, Tanaka H, Matsumura I. Taniguchi Y, et al. Among authors: miura m. Intern Med. 2020 Nov 1;59(21):2745-2749. doi: 10.2169/internalmedicine.4871-20. Epub 2020 Jul 7. Intern Med. 2020. PMID: 32641651 Free PMC article.

8

Evaluation of the plasma concentration of ponatinib in a chronic myeloid leukaemia patient with ponatinib intolerance.

Abumiya M, Takahashi N, Yoshioka T, Kameoka Y, Miura M. Abumiya M, et al. Among authors: miura m. J Clin Pharm Ther. 2021 Feb;46(1):219-222. doi: 10.1111/jcpt.13257. Epub 2020 Sep 28. J Clin Pharm Ther. 2021. PMID: 32985698

9

Relationship between Plasma Concentrations of Afatinib and the Onset of Diarrhea in Patients with Non-Small Cell Lung Cancer.

Yokota H, Sato K, Sakamoto S, Okuda Y, Asano M, Takeda M, Nakayama K, Miura M. Yokota H, et al. Among authors: miura m. Biology (Basel). 2021 Oct 17;10(10):1054. doi: 10.3390/biology10101054. Biology (Basel). 2021. PMID: 34681153 Free PMC article.

10

Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer.

Yokota H, Sato K, Sakamoto S, Okuda Y, Fukuda N, Asano M, Takeda M, Nakayama K, Miura M. Yokota H, et al. Among authors: miura m. Invest New Drugs. 2022 Dec;40(6):1254-1262. doi: 10.1007/s10637-022-01304-9. Epub 2022 Sep 23. Invest New Drugs. 2022. PMID: 36149549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,134 results

Search Page

Filters